CCOc1ccc(OCC)c(-c2c(=O)n(OCc3ccc(Cl)cc3)c3ccccc3[n+]2[O-])c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?